Previous Close | 1.1900 |
Open | 1.1800 |
Bid | 1.1400 x 400 |
Ask | 1.1800 x 100 |
Day's Range | 1.1300 - 1.2000 |
52 Week Range | 0.8000 - 2.1000 |
Volume | |
Avg. Volume | 1,128,838 |
Market Cap | 130.56M |
Beta (5Y Monthly) | -0.14 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2700 |
Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.50 |
OptiNose, Inc. ( NASDAQ:OPTN ) is possibly approaching a major achievement in its business, so we would like to shine...
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A